Individual differences mean that the costs of treatment of hypertension cannot readily be quantified

Norman M Kaplan

Research output: Contribution to journalArticle

Abstract

The costs of therapy for hypertension, as it becomes increasingly individualized, will be increasingly variable and difficult to pin down, making it nearly impossible, to quantify accurately.

Original languageEnglish (US)
Pages (from-to)1439-1441
Number of pages3
JournalCardiovascular Drugs and Therapy
Volume4
Issue number6
DOIs
StatePublished - Nov 1990

Fingerprint

Individuality
Health Care Costs
Hypertension
Costs and Cost Analysis
Therapeutics

Keywords

  • costs
  • hypertension
  • individual therapy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Individual differences mean that the costs of treatment of hypertension cannot readily be quantified. / Kaplan, Norman M.

In: Cardiovascular Drugs and Therapy, Vol. 4, No. 6, 11.1990, p. 1439-1441.

Research output: Contribution to journalArticle

@article{d0033c3c2fcc410782ed67a15f859e22,
title = "Individual differences mean that the costs of treatment of hypertension cannot readily be quantified",
abstract = "The costs of therapy for hypertension, as it becomes increasingly individualized, will be increasingly variable and difficult to pin down, making it nearly impossible, to quantify accurately.",
keywords = "costs, hypertension, individual therapy",
author = "Kaplan, {Norman M}",
year = "1990",
month = "11",
doi = "10.1007/BF02026488",
language = "English (US)",
volume = "4",
pages = "1439--1441",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "6",

}

TY - JOUR

T1 - Individual differences mean that the costs of treatment of hypertension cannot readily be quantified

AU - Kaplan, Norman M

PY - 1990/11

Y1 - 1990/11

N2 - The costs of therapy for hypertension, as it becomes increasingly individualized, will be increasingly variable and difficult to pin down, making it nearly impossible, to quantify accurately.

AB - The costs of therapy for hypertension, as it becomes increasingly individualized, will be increasingly variable and difficult to pin down, making it nearly impossible, to quantify accurately.

KW - costs

KW - hypertension

KW - individual therapy

UR - http://www.scopus.com/inward/record.url?scp=0025688675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025688675&partnerID=8YFLogxK

U2 - 10.1007/BF02026488

DO - 10.1007/BF02026488

M3 - Article

C2 - 2081136

AN - SCOPUS:0025688675

VL - 4

SP - 1439

EP - 1441

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 6

ER -